SCHEMBL127983

SCHEMBL127983

CCCOC(=O)CCC(C)C

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.47
CA1 P00915 2/20 0.43
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 3/20 0.40
ADRA2A P08913 1/20 0.40
ADRA1A P35348 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
DNM1 Q05193 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
ATM Q13315 1/20 0.39
BLM P54132 1/20 0.39
CYP19A1 P11511 1/20 0.39
HTR2C P28335 1/20 0.38
NAAA Q02083 1/20 0.38
MAPK1 P28482 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29062380 0.92 DGKA (0.41) DGKACA1ALDH1A1L3MBTL1MAPT
SCHEMBL127971 0.88 DGKA (0.53) DGKAALDH1A1L3MBTL1MAPTTDP1
SCHEMBL127529 0.88 DGKA (0.53) DGKAALDH1A1MAPTTDP1DNM1
SCHEMBL4292777 0.86 CYP19A1 (0.49) DGKACA1ALDH1A1MAPTADRA2A
SCHEMBL13970371 0.86 DGKA (0.57) DGKAALDH1A1L3MBTL1MAPTTDP1
SCHEMBL14944485 0.86 NAAA (0.57) DGKAALDH1A1MAPTTDP1DNM1
SCHEMBL14823560 0.85 BLM (0.46) DGKAALDH1A1L3MBTL1MAPTTDP1
SCHEMBL310867 0.85 MAPT (0.47) DGKAALDH1A1L3MBTL1MAPTADRA2A
SCHEMBL14308492 0.84 CA1 (0.44) DGKACA1MAPTADRA2AADRA1A
SCHEMBL25886908 0.84 CA1 (0.44) DGKACA1MAPTADRA2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 CN claimed
US-20070068792-A1 System and method for acetic acid dehydration AMT INTERNATIONAL, INC. 2007-03-29 US claimed
EP-4583177-A1 METHOD OF MANUFACTURING ELECTRODE, COMPOSITE ELECTRODE, ELECTROCHEMICAL ELEMENT, AND APPARATUS FOR MANUFACTURING ELECTRODE Ricoh Company, Ltd. (JP) 2025-07-09 EP disclosed
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 CN disclosed
EP-4362128-A1 LIQUID COMPOSITION, METHOD FOR PRODUCING LIQUID COMPOSITION, ELECTRODE, ELECTRODE PRODUCTION APPARATUS, AND METHOD FOR PRODUCING ELECTRODE Ricoh Company, Ltd. (JP) 2024-05-01 EP disclosed
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-21 US disclosed
US-20230314941-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-05 US disclosed
CN-115677632-A A method for preparing 5-hydroxy-4 isobutyl-2,5 dihydrofuran 2-one 珠海润都制药股份有限公司 2023-02-03 CN disclosed
CN-109952360-A Quantum dot dispersion liquid, self-luminous photosensitive polymer combination, the colour filter and image display device manufactured using it 东友精细化工有限公司 2019-06-28 CN disclosed
CN-109810589-A Light converts resin combination, light conversion layer folds substrate and image display device 东友精细化工有限公司 2019-05-28 CN disclosed
CN-109503587-A The antitumor action of double heterocycle ribavirin analogs and application 辽宁利锋科技开发有限公司 2019-03-22 CN disclosed
US-8450319-B2 Pyrrolopyridazinone compound UBE INDUSTRIES, LTD. (JP) 2013-05-28 US disclosed
US-20130122424-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-16 US disclosed
US-8324273-B2 Catechol protected levodopa diester prodrugs, compositions, and methods of use XENOPORT, INC. (US) 2012-12-04 US disclosed
EP-1982986-B1 PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR UBE INDUSTRIES (JP) 2012-03-07 EP disclosed
US-20090036453-A1 Pyrrolopyridazinone Compound UBE INDUSTRIES, LTD. (JP) 2009-02-05 US disclosed
WO-2008127646-A2 TRANSAMINASE-BASED PROCESSES FOR PREPARATION OF PREGABALIN DSM IP ASSETS B.V. (NL) 2008-10-23 WO disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed
US-20080171789-A1 Catechol protected levodopa diester prodrugs, compositions, and methods of use XENOPORT, INC. 2008-07-17 US disclosed
US-20070068792-A1 System and method for acetic acid dehydration AMT INTERNATIONAL, INC. 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern RER1, AFF1, AFF4 DGKA 3584/4885CA1 762/4885ALDH1A1 2890/4885
US-20090036453-A1 Pyrrolopyridazinone Compound CBR3, CBR1, CYC1 DGKA 3277/4885CA1 2208/4885ALDH1A1 580/4885
US-20080171789-A1 Catechol protected levodopa diester prodrugs, compositions, and methods of use COMT, PARK7, DDT DGKA 1421/4885CA1 2312/4885ALDH1A1 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.